Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cellectricon Presents Advanced Cell-based Assay Systems at ELA 2012

Published: Thursday, May 24, 2012
Last Updated: Thursday, May 24, 2012
Bookmark and Share
Speeding up research with novel cell manipulation and analysis platforms.

Cellectricon will be exhibiting at the European Laboratory Automation (ELA) conference and exhibition from 30-31 May. Onsite, Cellectricon will showcase and launch the Cellaxess® Elektra Discovery System for automated cellular electric field manipulation, and the recently launched Dynaflow® Resolve System. Furthermore, Dr. Johan Pihl, Cellaxess Product Manager, will be at booth #99 to provide both product information, and to present a poster on "High Throughput Transfections of Primary Neuronal Cells in HCA Applications".

ELA will provide researchers interested in cell-based applications, the opportunity to find out more about Cellectricon’s specialist systems. Research applications for primary cells, neurones and stem cells using Cellaxess® include; small molecule screening, through stimulation and voltage control of cell cultures; genomic screening, by transfection of siRNA and cDNA; and lead identification and target validation, via the delivery of small molecules, antibodies and peptides into cells.

Cellectricon will also showcase the newly launched Dynaflow® Resolve System, an add-on to existing patch-clamp setups that offers solution exchange at unsurpassed speed, control, and flexibility. Dynaflow® Resolve System drastically reduces experimental set-up and allows for reproducible execution of precise and robust patch-clamp experiments with minimal compound consumption. The system’s unique flexibility allows for the recording of any ion channel current, using any cell type, any compound, and for any experiment. The cost-effective microfluidic Dynaflow® Resolve chip incorporated is reusable, has 16 channels and is made of glass. The system also includes a computer controlled scan stage used to translate chip movements, software to control and pre-program the movements of the scan stage, and a pump to drive the liquid flow.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cellectricon Receives Milestone Order for Cellaxess®HT High Throughput RNAi Screening System
Cellectricon receives the largest single order to deliver three Cellaxess®HT systems to a leading US biotech firm.
Friday, November 14, 2008
Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
'Google Maps' for the Body
Scientists have revealed research that uses previously top-secret technology to zoom through the human body down to the level of a single cell that could be a game-changer for medicine.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Stem Cells Rescue Patients from Mitochondrial Disease
A study led by OHSU researchers has revealed a critical first step in developing a new gene and stem cell regenerative technique for treating patients with mitochondrial disease.
Eco-Friendly Nanobullet to Battle Bacteria
Researchers have developed a method to combat bacteria by engineering nanoscale particles that add the antimicrobial potency of silver to a core of lignin, a ubiquitous substance found in all plant cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!